aztreonam has been researched along with Splenic Diseases in 1 studies
Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.
Splenic Diseases: Diseases involving the SPLEEN.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakajima, F | 1 |
| Takaya, K | 1 |
| Hibi, S | 1 |
| Todo, S | 1 |
| Imashuku, S | 1 |
1 review available for aztreonam and Splenic Diseases
| Article | Year |
|---|---|
[Recombinant human granulocyte-colony stimulating factor (rhG-CSF) treatment for spleen abscess and periostitis in a patient with chronic granulomatous disease].
Topics: Abscess; Aztreonam; Ceftizoxime; Child; Chloramphenicol; Drug Therapy, Combination; Granulocyte Colo | 1992 |